SCHEMBL6934070

SCHEMBL6934070

CC=C(N)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.68
SOAT1 P35610 2/20 0.68
CYP1A2 P05177 2/20 0.68
CYP2C19 P33261 2/20 0.68
KMT2A Q03164 2/20 0.68
MEN1 O00255 1/20 0.68
TP53 P04637 1/20 0.68
CYP3A4 P08684 1/20 0.68
KDM4E B2RXH2 2/20 0.61
TERT O14746 3/20 0.57
PTPN1 P18031 3/20 0.57
PPARG P37231 3/20 0.57
PPARD Q03181 3/20 0.57
PPARA Q07869 3/20 0.57
MAPT P10636 2/20 0.57
BLM P54132 2/20 0.57
HSD17B10 Q99714 2/20 0.57
FABP4 P15090 2/20 0.57
GMNN O75496 1/20 0.57
USP2 O75604 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21602978 0.89 SPHK2 (0.54) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL28901737 0.89 SPHK2 (0.54) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL5691700 0.89 SPHK2 (0.54) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL16302453 0.89 SPHK2 (0.54) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL8459953 0.89 SPHK2 (0.54) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL4358496 0.89 SPHK2 (0.54) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL13448422 0.89 SPHK2 (0.54) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL21602979 0.89 SPHK2 (0.54) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL23273576 0.87
SCHEMBL7958181 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101657605-A Multi-component viscoelastic surfactant fluids and their use as fracturing fluids RHODIA US 2010-02-24 CN claimed
CN-1981014-A Multi-component viscoelastic surfactant fluids and their use as fracturing fluids RHODIA (US) 2007-06-13 CN claimed
EP-2817342-A1 POLYMERIZATION OF COMPOSITIONS COMPRISING A FARNESENE Amyris, Inc. (US) 2014-12-31 EP disclosed
US-RE45272-E1 β-glucuronide-linker drug conjugates SEATTLE GENETICS, INC. (US) 2014-12-02 US disclosed
CN-102155209-B Method for fracturing stratum by acidity viscoelastic fluid UNIV CHINA PETROLEUM 2014-01-01 CN disclosed
CN-102453481-B Acidic visco-elastic fluid, its preparation method and application thereof UNIV CHINA PETROLEUM BEIJING 2013-09-18 CN disclosed
WO-2013126129-A1 POLYMERIZATION OF COMPOSITIONS COMPRISING A FARNESENE Amyris, Inc. (US) 2013-08-29 WO disclosed
CN-102453481-A Acidic viscoelastic fluid and preparation method and application thereof UNIV CHINA PETROLEUM BEIJING 2012-05-16 CN disclosed
CN-102155209-A Method for fracturing stratum by acidity viscoelastic fluid UNIV CHINA PETROLEUM 2011-08-17 CN disclosed
EP-0852140-B1 METHODS FOR MAKING HARDLY SOLUBLE MEDICINE AMORPHOUS NISSAN CHEMICAL IND LTD (JP) 2003-12-03 EP disclosed
EP-1356807-A2 Method for converting sparingly water-soluble medical substance to amorphous state NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 2003-10-29 EP disclosed
US-6462093-B1 Method for converting sparingly water-soluble medical substance to amorphous state NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2002-10-08 US disclosed
CN-1089232-C Method for making hardly soluble medicine amorphous NISSAN CHEMICAL IND LTD (JP) 2002-08-21 CN disclosed
CN-1192677-A Method for making hardly soluble medicine amorphous NISSAN CHEMICAL IND LTD (JP) 1998-09-09 CN disclosed
EP-0852140-A1 METHODS FOR MAKING HARDLY SOLUBLE MEDICINE AMORPHOUS NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1998-07-08 EP disclosed